BB

Banya Basu

Active Director Director DIN 01881519
DIN 01881519 First appointment Jan 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2008
Shareholding value •••• Premium profile

About Banya Basu

Data last updated:

Banya Basu is a Director at Sai Bio Pharma Products Private Limited (since 2008). The company operates in Pharma. Sai Bio Pharma Products Private Limited reported revenue of ₹5.4 Lakh (FY 2019).

DIN 01881519
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2008
Oldest Company Age 18 yrs
Largest company Sai Bio Pharma Products Private Limited · ₹5.4 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jan 20082008₹5.4 Lakh (FY 2019)Active

Board colleagues of Banya Basu

NameDINCompanyDesignation
Goutam Goswami02696484Sai Bio Pharma Products Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sai Bio Pharma Products Private Limited
Premium access

Shareholding and investment profile for Banya Basu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Banya Basu

Banya Basu currently holds 1 directorship: Sai Bio Pharma Products Private Limited (Director, since 11 Jan 2008, revenue ₹5.4 Lakh (FY 2019)).

Banya Basu was first appointed on 11 Jan 2008 as Director at Sai Bio Pharma Products Private Limited.

The current boards of Banya Basu's companies include Goutam Goswami (Sai Bio Pharma Products Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available